Flow-augmentation bypassACVD
…ncy was 96.3%, with 3.7% experiencing recurrent TIAs.Conclusion Flow-augmentation bypass remains a valuable option in carefully selected ACVD patients w…
Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
This treatment is selected. Its supporting articles are shown below.
…ncy was 96.3%, with 3.7% experiencing recurrent TIAs.Conclusion Flow-augmentation bypass remains a valuable option in carefully selected ACVD patients w…